Brief: Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance
26/06/2023 22:08
Aptose Biosciences Inc APS.TO :
* APTOSE BIOSCIENCES MEETS NASDAQ MINIMUM BID PRICE
COMPLIANCE
Source text for Eikon: ID:nGNX5Sjdk0
Further company coverage: APS.TO
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting